Related Experiment Video
Updated: Aug 28, 2025

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies
Qiongyu Hao1, Yanyuan Wu1,2, Jaydutt V Vadgama1,2
1Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Abstract:
Prostate cancer is one of the leading causes of death for men worldwide. The development of resistance, toxicity, and side effects of conventional therapies have made prostate cancer treatment become more intensive and aggressive. Many phytochemicals isolated from plants have shown to be tumor cytotoxic. In vitro laboratory studies have revealed that natural compounds can affect cancer cell proliferation by modulating many crucial cellular signaling pathways frequently dysregulated in prostate cancer. A multitude of natural compounds have been found to induce cell cycle arrest, promote apoptosis, inhibit cancer cell growth, and suppress angiogenesis. In addition, combinatorial use of natural compounds with hormone and/or chemotherapeutic drugs seems to be a promising strategy to enhance the therapeutic effect in a less toxic manner, as suggested by pre-clinical studies. In this context, we systematically reviewed the currently available literature of naturally occurring compounds isolated from vegetables, fruits, teas, and herbs, with their relevant mechanisms of action in prostate cancer. As there is increasing data on how phytochemicals interfere with diverse molecular pathways in prostate cancer, this review discusses and emphasizes the implicated molecular pathways of cell proliferation, cell cycle control, apoptosis, and autophagy as important processes that control tumor angiogenesis, invasion, and metastasis. In conclusion, the elucidation of the natural compounds' chemical structure-based anti-cancer mechanisms will facilitate drug development and the optimization of drug combinations. Phytochemicals, as anti-cancer agents in the treatment of prostate cancer, can have significant health benefits for humans.
Insights
Natural compounds from plants, known as phytochemicals, show promise in fighting prostate cancer. These natural agents can inhibit cancer growth and may enhance conventional treatments with fewer side effects.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- Prostate cancer is a leading cause of male mortality worldwide.
- Conventional therapies face challenges due to resistance, toxicity, and side effects.
- Phytochemicals from plants exhibit cytotoxic properties against tumors.
Purpose of the Study:
- To systematically review literature on naturally occurring compounds for prostate cancer treatment.
- To elucidate the mechanisms of action of these phytochemicals.
- To explore their role in modulating key cancer pathways.
Main Methods:
- Systematic literature review of naturally occurring compounds.
- Analysis of in vitro and pre-clinical studies.
- Focus on compounds isolated from vegetables, fruits, teas, and herbs.
Main Results:
- Phytochemicals modulate crucial cellular signaling pathways in prostate cancer.
- Natural compounds induce cell cycle arrest, apoptosis, and inhibit angiogenesis.
- Combinatorial use with conventional drugs shows potential for enhanced efficacy and reduced toxicity.
Conclusions:
- Phytochemicals offer a promising avenue for prostate cancer treatment, potentially with significant health benefits.
- Understanding their structure-based anti-cancer mechanisms can aid drug development and combination therapies.
- Natural compounds can interfere with cell proliferation, cell cycle control, apoptosis, autophagy, angiogenesis, invasion, and metastasis.
Related Concept Videos
Inhibition of Cdk Activity
Cancer Prevention
Some...
Enzyme Inhibition
Negative Regulator Molecules
Drugs that Stabilize Microtubules
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

